UCL logo
skip to navigation. skip to content.

UCL Cancer Institute

School of Life and Medical Sciences
UCL Home
  • UCL Home
  • UCL Cancer Institute
  • About Us


UCL Cancer Institute
UCL Cancer Institute
About Us
  • Home Page
  • Who we are
  • Paul O'Gorman
  • CR-UK Cancer Centre
  • Our Strategy Plan
  • UCL-Partners
  • Vacancies & Fellowships
  • Find Us
  • Staff Directory
  • Conferences & Events
  • Links for Patients & Research
  • News
  • Newsletter

Cancer Biology Dept of Haematology Dept of Oncology Dept of Pathology Clinical Trials Support Services Education Support US Staff Resources

Cancer Institute Newsletter



ISSUE 2  Autumn 2011

This issue of our Newsletter highlights the progress over the summer months to establish a truly comprehensive Cancer Institute in the heart of London, promoting fundamental research, education and clinical trials. This issue also features the research of three scientists from the newly formed Cancer Domain, a cross-faculty initiative bringing together all cancerrelated activities at UCL, ranging from nanoengineering and physics through to applied clinical research. The scientists featured are Professor Sir Salvador Moncada (Wolfson Institute for Biomedical Research), Professor Clare Futter (Institute of Ophthalmology) and Professor Usha Menon (Institute of Women’s Health).

UCL is located within one of the most culturally diverse cities in the world. On page 12, we show our ongoing efforts at the Institute to promote diversity in our workforce.

   

  • Download


ISSUE 1  Spring 2011

The UCL Cancer Institute is now fully established with 50 scientific group leads, 32 clinical scientists, 50 honorary clinical consultants and a total staff FTE of 317.

During the past 3 years our total research grant income has increased by 40% to nearly £50million.

During the next year a number of exciting developments will affect cancer research at UCL: the completion of the £100million UCH Macmillan Cancer Centre opposite our main research hub in Huntley Street; the recruitment of a radiation oncology lead to develop the proton treatment facility with UCLH and the expansion of molecular pathology research, supporting personalised cancer clinical trials and care.

I hope that this newsletter will give you a sense of the exciting new developments.

Chris Boshoff Director, UCL Cancer Institute

   

  • Download


 
  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Privacy
  • Advanced Search
  • Contact Us
University College London - Gower Street - London - WC1E 6BT Tel: +44 (0)20 7679 2000

© UCL 1999–

Search by Google edit page